ACADIA PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of DR6 for the last quarter is 190.76 M EUR, and it's 8.87% lower compared to the previous quarter. The net income of Q1 24 is 15.34 M EUR.